Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Yoshitaka Hobo in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Miyoko Higuchi in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Shuji Fukata in
Google Scholar
PubMed
Search for other papers by Mitsushige Nishikawa in
Google Scholar
PubMed
Search for other papers by Takashi Akamizu in
Google Scholar
PubMed
M Wang CC Guttler RB Singer PA Fatemi S LoPresti JS Nicoloff JT . Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma
Search for other papers by Eftychia Koukkou in
Google Scholar
PubMed
Search for other papers by Ioannis Ilias in
Google Scholar
PubMed
Search for other papers by Irene Mamalis in
Google Scholar
PubMed
Search for other papers by Georgios G. Adonakis in
Google Scholar
PubMed
Search for other papers by Kostas B. Markou in
Google Scholar
PubMed
UIC is highly influenced by recent iodine intake, it can only be used to determine iodine status for populations and not for individuals [ 9 ]. Serum thyroglobulin (Tg) may also be a suitable marker of the current iodine status in a population
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Cláudia C.D. Nakabashi in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Search for other papers by Felipe Crispim in
Google Scholar
PubMed
Search for other papers by Claudia A. Yamazaki in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Cléber P. Camacho in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Danielle M. Andreoni in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Rosalia P. Padovani in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Elza S. Ikejiri in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Maria C.O.M. Mamone in
Google Scholar
PubMed
Search for other papers by Flávia C. Aldighieri in
Google Scholar
PubMed
Search for other papers by Jairo Wagner in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Search for other papers by Jairo T. Hidal in
Google Scholar
PubMed
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by José G.H. Vieira in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Rosa P.M. Biscolla in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
a nonsignificant risk of recurrence from undergoing unnecessary investigations and identify those individuals with a higher risk who merit closer follow-up [ 6 , 7 ]. The measurement of serum thyroglobulin (Tg) levels is one of the most important
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Jens Bentzen in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Search for other papers by Susanne Møller Pedersen in
Google Scholar
PubMed
Search for other papers by Lars Bastholt in
Google Scholar
PubMed
Search for other papers by Aase Handberg in
Google Scholar
PubMed
Search for other papers by Carsten Rytter in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Search for other papers by Jens Faber in
Google Scholar
PubMed
]. International guidelines [ 4 , 5 ] suggest a differentiation of patients into low and high risk, low risk patients having a life expectancy close to that of the background population. Serum thyroglobulin (s-Tg) is used as a tumor marker during follow-up after
Search for other papers by Till Ittermann in
Google Scholar
PubMed
German Rheumatism Research Center, Berlin, Germany
Search for other papers by Adrian Richter in
Google Scholar
PubMed
Search for other papers by Martin Junge in
Google Scholar
PubMed
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Institute for Clinical Chemistry, Interdisciplinary University Laboratory, University Medicine Göttingen, Göttingen, Germany
Search for other papers by Astrid Petersmann in
Google Scholar
PubMed
Search for other papers by Clemens Jürgens in
Google Scholar
PubMed
Search for other papers by Harald Below in
Google Scholar
PubMed
Search for other papers by Carsten Oliver Schmidt in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
agreement over the twelve visits, with mean differences of 0.09 mIU/L and 0.21 pmol/L and SDs of 0.06 mIU/L and 0.14 pmol/L, respectively. Very good agreements across the visits were observed for serum thyroglobulin level and thyroid volume. For the
Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed
Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed
Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed
Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed
Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed
Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed
Search for other papers by Maria Prado Talavera Rubio in
Google Scholar
PubMed
Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed
Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed
Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed
risk of recurrence. Thyroid 2011; 21: 49–53. 25 Pelttari H, Välimäki MJ, Löyttyniemi E, Schalin-Jäntti C: Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow
Search for other papers by Chitra Choudhary in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Eshetu Tefera in
Google Scholar
PubMed
Search for other papers by Kenneth D. Burman in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer patients are monitored for local or distant recurrence after total thyroidectomy. They typically undergo physical examination, serial measurement of serum thyroglobulin (Tg) levels, and serial
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Federica Brozzi in
Google Scholar
PubMed
Search for other papers by Pierina Santini in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by David Viola in
Google Scholar
PubMed
Search for other papers by Loredana Lorusso in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Endocrinol Metab . 2013 Feb ; 98 ( 2 ): 636 – 42 . 10.1210/jc.2012-3401 23293334 0021-972X 14 Padovani RP , Robenshtok E , Brokhin M , Tuttle RM . Even without additional therapy, serum thyroglobulin concentrations often decline for
Search for other papers by Fahim U. Hassan in
Google Scholar
PubMed
Search for other papers by Hosahalli K. Mohan in
Google Scholar
PubMed
undertaken) and clinical follow-up, including serum thyroglobulin monitoring for up to 2 years post-therapy. Any other correlative imaging information including neck ultrasound was also collected. Results A large majority of patients, i.e. 57
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
299 374 – 380 . ( https://doi.org/10.1148/radiol.2021201596 ) 10 Park S Jeon MJ Oh HS Lee YM Sung TY Han M Han JM Kim TY Chung KW Kim WB , Changes in serum thyroglobulin levels after lobectomy in patients with low-risk papillary